Literature DB >> 23131770

Immunological and biochemical markers in preeclampsia.

A Kestlerová1, J Feyereisl, V Frisová, A Měchurová, K Šůla, T Zima, J Běláček, J Madar.   

Abstract

A basic precondition for the development of preeclampsia is the presence of placental trophoblast cells in the maternal blood circulation. On the other hand, while trophoblast cells are present in the blood of all pregnant women, preeclampsia occurs in only 2-5% of them. Evidently, other factors play a crucial role. The aim of this study was to compare a set of selected immunological factors (anti-cardiolipin autoantibodies, trophoblast-induced cell-mediated immunity, C3 and C4 complement components) and biochemical factors (serum immunoglobulins IgA, IgG, IgM) among three groups of women with uncomplicated pregnancy, gestational hypertension, or preeclampsia. Blood samples were taken 2-12h before delivery. In the preeclampsia group, there was a significantly higher number of women positive for anti-cardiolipin autoantibodies, trophoblast-induced cell-mediated immunity was elevated, serum IgG was elevated and C4 complement component was reduced. We conclude that both elevated autoimmune reactivity and the higher immune reactivity to trophoblast may contribute to the onset of preeclampsia.
Copyright © 2012. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23131770     DOI: 10.1016/j.jri.2012.10.002

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  8 in total

Review 1.  Obesity "complements" preeclampsia.

Authors:  Kelsey N Olson; Leanne M Redman; Jenny L Sones
Journal:  Physiol Genomics       Date:  2019-02-04       Impact factor: 3.107

2.  Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat.

Authors:  Jean F Regal; Megan E Strehlke; Jenna M Peterson; Cameron R Wing; Jordan E Parker; Noel Fernando Nieto; Lynne T Bemis; Jeffrey S Gilbert; Sherry D Fleming
Journal:  Mol Immunol       Date:  2016-08-30       Impact factor: 4.407

3.  Role of B1 and B2 lymphocytes in placental ischemia-induced hypertension.

Authors:  Connor F Laule; Evan J Odean; Cameron R Wing; Kate M Root; Kendra J Towner; Cassandra M Hamm; Jeffrey S Gilbert; Sherry D Fleming; Jean F Regal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-09       Impact factor: 4.733

Review 4.  Review of the immune mechanisms of preeclampsia and the potential of immune modulating therapy.

Authors:  Ai-Ris Y Collier; Laura A Smith; S Ananth Karumanchi
Journal:  Hum Immunol       Date:  2021-02-05       Impact factor: 2.850

5.  Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father.

Authors:  Louise C Kenny; Douglas B Kell
Journal:  Front Med (Lausanne)       Date:  2018-01-04

Review 6.  Dysregulation of Complement Activation and Placental Dysfunction: A Potential Target to Treat Preeclampsia?

Authors:  E Pierik; Jelmer R Prins; Harry van Goor; Gustaaf A Dekker; Mohamed R Daha; Marc A J Seelen; Sicco A Scherjon
Journal:  Front Immunol       Date:  2020-01-15       Impact factor: 7.561

7.  Two variants of the C-reactive protein gene are associated with risk of pre-eclampsia in an American Indian population.

Authors:  Lyle G Best; Richa Saxena; Cindy M Anderson; Michael R Barnes; Hakon Hakonarson; Gilbert Falcon; Candelaria Martin; Berta Almoguera Castillo; Ananth Karumanchi; Kylie Keplin; Nichole Pearson; Felicia Lamb; Shellee Bercier; Brendan J Keating
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

8.  Complement regulation in ovine lymph nodes during early pregnancy.

Authors:  Leying Zhang; Lidong Cao; Pengfei Feng; Xu Han; Ling Yang
Journal:  Exp Ther Med       Date:  2021-12-23       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.